Correlation Between Isras Investment and Epitomee Medical

Can any of the company-specific risk be diversified away by investing in both Isras Investment and Epitomee Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Isras Investment and Epitomee Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Isras Investment and Epitomee Medical, you can compare the effects of market volatilities on Isras Investment and Epitomee Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Isras Investment with a short position of Epitomee Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Isras Investment and Epitomee Medical.

Diversification Opportunities for Isras Investment and Epitomee Medical

0.37

Correlation Coefficient

Isras Investment  Epitomee Medical

Weak diversification

The 3 months correlation between Isras and Epitomee is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Isras Investment and Epitomee Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Epitomee Medical and Isras Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Isras Investment are associated (or correlated) with Epitomee Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Epitomee Medical has no effect on the direction of Isras Investment i.e., Isras Investment and Epitomee Medical go up and down completely randomly.

Pair Corralation between Isras Investment and Epitomee Medical

Assuming the 90 days trading horizon Isras Investment is expected to under-perform the Epitomee Medical. But the stock apears to be less risky and, when comparing its historical volatility, Isras Investment is 5.26 times less risky than Epitomee Medical. The stock trades about -0.07 of its potential returns per unit of risk. The Epitomee Medical is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  92,150  in Epitomee Medical on September 30, 2024 and sell it today you would earn a total of  2,600  from holding Epitomee Medical or generate 2.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Isras Investment  vs.  Epitomee Medical

Isras Investment

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Isras Investment are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Isras Investment sustained solid returns over the last few months and may actually be approaching a breakup point.

Epitomee Medical

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Epitomee Medical are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Epitomee Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Isras Investment and Epitomee Medical

The main advantage of trading using opposite Isras Investment and Epitomee Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Isras Investment position performs unexpectedly, Epitomee Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Epitomee Medical will offset losses from the drop in Epitomee Medical's long position.

The idea behind Isras Investment and Epitomee Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .